Paris-Sana
The National Agency for the Safety of Medicines and Health Products in France has renewed its warning against the use of the drug hydroxychloroquine in the fight against the emerging coronavirus, at a time of increasing concern about its side effects.
The agency quoted the agency as saying today that more than half of the 321 cases of unacceptable side effects of the drugs currently used for Coronavirus are caused by the drug hydroxychloroquine and the anti-inflammatory used with it azetromycin.
The agency reported that since the epidemic appeared, serious side effects were reported in 80 percent of the reported cases, noting that four deaths in French hospitals as a result of side effects from the treatments used for Coronavirus were linked to hydroxychloroquine.
US President Donald Trump considered that this drug would change the rules of the game previously, and the National Agency for the Safety of Medicines and Health Products in France issued a warning about the anti-malarial drug that is also used to treat lupus and rheumatoid arthritis.
And the European Medicines Agency included its voice for the anxious voices of the use of malaria drugs, clarifying in a statement the day before yesterday that recent studies recorded serious heartbeat problems and in some cases fatal when using chloroquine or hydroxychloroquine, especially when used in high doses or alongside the anti-inflammatory azitromycin, pointing to the lack of Any indication that these medications are useful in treating people with the virus.